Propiverine-induced Parkinsonism: A case report and a pharmacokinetic/pharmacodynamic study in mice

Hirotami Matsuo, Akiko Matsui, Risa Nasu, Hitomi Takanaga, Naohide Inoue, Fumitada Hattori, Hisakazu Ohtani, Yasufumi Sawada

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Purpose. We present a case report of propiverine-induced Parkinsonism. We previously reported the induction of catalepsy by amiodarone, aprindine and procaine, which possess a diethylaminomethyl moiety and demonstrated selective blockade of dopamine D2 receptors by these drugs in mice. We hypothesized that drugs possessing a diethylaminomethyl structure may generally induce Parkinsonism and/or catalepsy. Methods. Thus, we performed a study to examine whether oxybutynin, pentoxyverine and etafenone, as well as propiverine, induce catalepsy in mice. Results. The intensity of drug-induced catalepsy was in the order: haloperidol > etafenone > pentoxyverine > propiverine > oxybutynin. In vivo occupancy of dopamine D1, D2 and mACh receptors in the striatum was also examined. The in vitro binding affinities to the D1, D2 and mACh receptors in the striatum synaptic membrane were within the ranges of 2.4-140 μM, 380-4,200 nM, and 1.2-2,800 nM, respectively. Conclusions. These results support the idea that any drug possessing a diethylaminomethyl moiety may contribute to the induction of catalepsy, possibly by occupying dopamine receptors.

Original languageEnglish
Pages (from-to)565-571
Number of pages7
JournalPharmaceutical Research
Volume17
Issue number5
DOIs
Publication statusPublished - 2000
Externally publishedYes

Fingerprint

Pharmacodynamics
Catalepsy
Pharmacokinetics
Parkinsonian Disorders
Pharmaceutical Preparations
Mach number
Aprindine
Procaine
Dopamine D2 Receptors
Amiodarone
Dopamine Receptors
Haloperidol
Synaptic Membranes
Dopamine
Membranes
propiverine
etafenone
carbetapentane
oxybutynin

Keywords

  • Catalepsy
  • Diethylaminomethyl
  • Dopamine receptor
  • Drug-induced Parkinsonism
  • Propiverine
  • Receptor occupancy

ASJC Scopus subject areas

  • Chemistry(all)
  • Pharmaceutical Science
  • Pharmacology

Cite this

Matsuo, H., Matsui, A., Nasu, R., Takanaga, H., Inoue, N., Hattori, F., ... Sawada, Y. (2000). Propiverine-induced Parkinsonism: A case report and a pharmacokinetic/pharmacodynamic study in mice. Pharmaceutical Research, 17(5), 565-571. https://doi.org/10.1023/A:1007516916077

Propiverine-induced Parkinsonism : A case report and a pharmacokinetic/pharmacodynamic study in mice. / Matsuo, Hirotami; Matsui, Akiko; Nasu, Risa; Takanaga, Hitomi; Inoue, Naohide; Hattori, Fumitada; Ohtani, Hisakazu; Sawada, Yasufumi.

In: Pharmaceutical Research, Vol. 17, No. 5, 2000, p. 565-571.

Research output: Contribution to journalArticle

Matsuo, H, Matsui, A, Nasu, R, Takanaga, H, Inoue, N, Hattori, F, Ohtani, H & Sawada, Y 2000, 'Propiverine-induced Parkinsonism: A case report and a pharmacokinetic/pharmacodynamic study in mice', Pharmaceutical Research, vol. 17, no. 5, pp. 565-571. https://doi.org/10.1023/A:1007516916077
Matsuo, Hirotami ; Matsui, Akiko ; Nasu, Risa ; Takanaga, Hitomi ; Inoue, Naohide ; Hattori, Fumitada ; Ohtani, Hisakazu ; Sawada, Yasufumi. / Propiverine-induced Parkinsonism : A case report and a pharmacokinetic/pharmacodynamic study in mice. In: Pharmaceutical Research. 2000 ; Vol. 17, No. 5. pp. 565-571.
@article{2044f946f6b04a50a82f72757e584614,
title = "Propiverine-induced Parkinsonism: A case report and a pharmacokinetic/pharmacodynamic study in mice",
abstract = "Purpose. We present a case report of propiverine-induced Parkinsonism. We previously reported the induction of catalepsy by amiodarone, aprindine and procaine, which possess a diethylaminomethyl moiety and demonstrated selective blockade of dopamine D2 receptors by these drugs in mice. We hypothesized that drugs possessing a diethylaminomethyl structure may generally induce Parkinsonism and/or catalepsy. Methods. Thus, we performed a study to examine whether oxybutynin, pentoxyverine and etafenone, as well as propiverine, induce catalepsy in mice. Results. The intensity of drug-induced catalepsy was in the order: haloperidol > etafenone > pentoxyverine > propiverine > oxybutynin. In vivo occupancy of dopamine D1, D2 and mACh receptors in the striatum was also examined. The in vitro binding affinities to the D1, D2 and mACh receptors in the striatum synaptic membrane were within the ranges of 2.4-140 μM, 380-4,200 nM, and 1.2-2,800 nM, respectively. Conclusions. These results support the idea that any drug possessing a diethylaminomethyl moiety may contribute to the induction of catalepsy, possibly by occupying dopamine receptors.",
keywords = "Catalepsy, Diethylaminomethyl, Dopamine receptor, Drug-induced Parkinsonism, Propiverine, Receptor occupancy",
author = "Hirotami Matsuo and Akiko Matsui and Risa Nasu and Hitomi Takanaga and Naohide Inoue and Fumitada Hattori and Hisakazu Ohtani and Yasufumi Sawada",
year = "2000",
doi = "10.1023/A:1007516916077",
language = "English",
volume = "17",
pages = "565--571",
journal = "Pharmaceutical Research",
issn = "0724-8741",
publisher = "Springer New York",
number = "5",

}

TY - JOUR

T1 - Propiverine-induced Parkinsonism

T2 - A case report and a pharmacokinetic/pharmacodynamic study in mice

AU - Matsuo, Hirotami

AU - Matsui, Akiko

AU - Nasu, Risa

AU - Takanaga, Hitomi

AU - Inoue, Naohide

AU - Hattori, Fumitada

AU - Ohtani, Hisakazu

AU - Sawada, Yasufumi

PY - 2000

Y1 - 2000

N2 - Purpose. We present a case report of propiverine-induced Parkinsonism. We previously reported the induction of catalepsy by amiodarone, aprindine and procaine, which possess a diethylaminomethyl moiety and demonstrated selective blockade of dopamine D2 receptors by these drugs in mice. We hypothesized that drugs possessing a diethylaminomethyl structure may generally induce Parkinsonism and/or catalepsy. Methods. Thus, we performed a study to examine whether oxybutynin, pentoxyverine and etafenone, as well as propiverine, induce catalepsy in mice. Results. The intensity of drug-induced catalepsy was in the order: haloperidol > etafenone > pentoxyverine > propiverine > oxybutynin. In vivo occupancy of dopamine D1, D2 and mACh receptors in the striatum was also examined. The in vitro binding affinities to the D1, D2 and mACh receptors in the striatum synaptic membrane were within the ranges of 2.4-140 μM, 380-4,200 nM, and 1.2-2,800 nM, respectively. Conclusions. These results support the idea that any drug possessing a diethylaminomethyl moiety may contribute to the induction of catalepsy, possibly by occupying dopamine receptors.

AB - Purpose. We present a case report of propiverine-induced Parkinsonism. We previously reported the induction of catalepsy by amiodarone, aprindine and procaine, which possess a diethylaminomethyl moiety and demonstrated selective blockade of dopamine D2 receptors by these drugs in mice. We hypothesized that drugs possessing a diethylaminomethyl structure may generally induce Parkinsonism and/or catalepsy. Methods. Thus, we performed a study to examine whether oxybutynin, pentoxyverine and etafenone, as well as propiverine, induce catalepsy in mice. Results. The intensity of drug-induced catalepsy was in the order: haloperidol > etafenone > pentoxyverine > propiverine > oxybutynin. In vivo occupancy of dopamine D1, D2 and mACh receptors in the striatum was also examined. The in vitro binding affinities to the D1, D2 and mACh receptors in the striatum synaptic membrane were within the ranges of 2.4-140 μM, 380-4,200 nM, and 1.2-2,800 nM, respectively. Conclusions. These results support the idea that any drug possessing a diethylaminomethyl moiety may contribute to the induction of catalepsy, possibly by occupying dopamine receptors.

KW - Catalepsy

KW - Diethylaminomethyl

KW - Dopamine receptor

KW - Drug-induced Parkinsonism

KW - Propiverine

KW - Receptor occupancy

UR - http://www.scopus.com/inward/record.url?scp=0034099580&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034099580&partnerID=8YFLogxK

U2 - 10.1023/A:1007516916077

DO - 10.1023/A:1007516916077

M3 - Article

C2 - 10888308

AN - SCOPUS:0034099580

VL - 17

SP - 565

EP - 571

JO - Pharmaceutical Research

JF - Pharmaceutical Research

SN - 0724-8741

IS - 5

ER -